Skip to main content
Log in

Target fasting glycaemia for pump-treated type-i diabetics

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In 17 type-I diabetic patients on continuous s.c. insulin infusion (CSII) therapy, potential interrelationships between fasting levels of blood glucose (BG), serum free insulin (free IRI), total (free and bound) insulin (total IRI) and insulinbinding immunglobulin G (IgGI) were evaluated. There was no consistent relationship between the basal s.c. infused insulin dosages and the associated insulinaemia or glycaemia. A significant inverse correlation was found between the fasting levels of serum free IRI and BG (P<0.005). On the basis of this interrelationship, a target range of 90–110 mg/dl for fasting BG during CSII treatment is proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bar RS, Gorden P, Roth J, Siebert C (1977) Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration. J Clin Endocrinol Metab 44:120–1213

    Google Scholar 

  2. Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P (1982) Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 5:77–91

    Google Scholar 

  3. Berger M, Sonnenberg GE, Chantelau EA (1982) Insulin pump treatment for diabetes: some questions can be answered already. Clin Physiol 2:351–355

    Google Scholar 

  4. Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich J (1983) Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134–141

    Google Scholar 

  5. Editorial (1982) Type I diabetes ... regimens, targets, and caveats. Diabetes Care 5:547–552

  6. Gale EAM, Kurtz AB, Tattersall RB (1980) In search of the Somogyi effect. Lancet II:279–282

    Google Scholar 

  7. Gerich JE, Rizza RA, Verdonk CA (1981) Effect of plasma glucose concentration on production, utilization, and clearence of glucose in man. Proceedings of the International Symposium on Artificial Systems for Insulin Delivery, 20–23 Sept 1981, Assisi (Perugia), Italy; abstr. 51

  8. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH (1975) Proinsulin, insulin, and c-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278–1283

    Google Scholar 

  9. Kruse V (1981) Effect of insulin-binding antibodies on free insulin in plasma and tissue after subcutaneous injection. In: Keck K, Erb P (eds) Basic and clinical aspects of immunity to insulin. Walter de Gruyter & Co., New York Berlin

    Google Scholar 

  10. Lock DR, Rigg LA (1981) Hypoglycaemic coma associated with subcutaneous insulin infusion by portable pump. Diabetes Care 4:389–391

    Google Scholar 

  11. Malone JI, Root AW (1981) Plasma free insulin concentrations: keystone to effective management of diabetes mellitus in children. J Pediatr 99:862–867

    Google Scholar 

  12. Pedersen O, Beck-Nielsen H, Heding L (1980) Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med 302:886–892

    Google Scholar 

  13. Peterson CM (1982) History and goals of insulin treatment (Symposium on optimal insulin delivery). Diabetes Care 5, Suppl 1:1–5

    Google Scholar 

  14. Pickup JC (1982) Continuous subcutaneous insulin infusion. Br Med J 285:49–50

    Google Scholar 

  15. Pickup JC, Viberti GC, Bilous RW, Keen H, Alberti KGMM, Home PD, Binder C (1982) Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 22:175–179

    Google Scholar 

  16. Raskin P (1982) Treatment of type I diabetes with portable insulin infusion devices. Diabetes Care 5, Suppl 1:48–52

    Google Scholar 

  17. Skyler JS, Seigler DE, Reeves ML (1982) Optimizing pumped insulin delivery. Diabetes Care 5:135–139

    Google Scholar 

  18. Sonnenberg GE, Chantelau E, Berger M (1981) Ein neues therapeutisches Prinzip in der Diabetologie: kontinuierliche Insulin-Infusion mittels portabler Pumpen. Dtsch Med Wochenschr 106:891–893

    Google Scholar 

  19. Sonnenberg GE, Chantelau E, Berger M (1982) Mismanagement of insulin pumps. Diabetes Care 5:145 (letter)

    Google Scholar 

  20. Unger RH (1982) Meticulous control of diabetes: benefits, risks and precautions. Diabetes 31:479–483

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was in part presented at the 18th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Budapest, Hungary, 1–4 September 1982

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chantelau, E.A., Sonnenberg, G.E., Best, F. et al. Target fasting glycaemia for pump-treated type-i diabetics. Klin Wochenschr 62, 328–330 (1984). https://doi.org/10.1007/BF01716450

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01716450

Key words

Navigation